Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$9.50 +0.45 (+4.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Phathom Pharmaceuticals (PHAT) EV to FCF (2019 - 2026)

Analysis

Phathom Pharmaceuticals (PHAT) EV to FCF (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Phathom Pharmaceuticals 796.85 Mn 611.51 Mn 59.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -354.10
Mar 31, 2026 -44.18
Dec 31, 2025 -172.94
Sep 30, 2025 -49.37
Jun 30, 2025 -8.28
Mar 31, 2025 -2.61
Dec 31, 2024 -4.04
Sep 30, 2024 -14.11
Jun 30, 2024 -4.59
Mar 31, 2024 -4.29
Dec 31, 2023 -3.45
Sep 30, 2023 -10.60
Jun 30, 2023 -25.29
Mar 31, 2023 -4.54
Dec 31, 2022 -7.46
Sep 30, 2022 -7.36
Jun 30, 2022 -4.44
Mar 31, 2022 -8.48
Dec 31, 2021 -10.08
Sep 30, 2021 -25.44